Overexpression of Smac by an Armed Vesicular Stomatitis Virus Overcomes Tumor Resistance
Authors:
Open Access
- 1 September 2019
- journal article
- research article
- Published by Elsevier in Molecular Therapy-Oncolytics
- Vol. 14, 188-195
Abstract
No abstract availableKeywords
Funding Information
- Georgia Research Alliance
This publication has 50 references indexed in Scilit:
- Complete Eradication of Xenograft Hepatoma by Oncolytic Adenovirus ZD55 Harboring TRAIL-IETD-Smac Gene with Broad Antitumor EffectHuman Gene Therapy, 2012
- Lesion Development and Replication Kinetics During Early Infection in Cattle Inoculated With Vesicular Stomatitis New Jersey Virus Via Scarification and Black Fly (Simulium vittatum) BiteVeterinary Pathology, 2010
- Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancerBreast Cancer Research, 2009
- Early Steps of the Virus Replication Cycle Are Inhibited in Prostate Cancer Cells Resistant to Oncolytic Vesicular Stomatitis VirusJournal of Virology, 2008
- Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancerOncogene, 2007
- ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour propertiesGene Therapy, 2003
- Identification of DIABLO, a Mammalian Protein that Promotes Apoptosis by Binding to and Antagonizing IAP ProteinsCell, 2000
- Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP InhibitionCell, 2000
- Localized attenuation and discontinuous synthesis during vesicular stomatitis virus transcriptionCell, 1981
- Determination of molar ratios of vesicular stomatitis virus induced RNA species in BHK21cellsBiochemistry, 1976